Table 2.

Management and outcomes.

	Overall population (n = 169)	No coronary calcification (n = 64)	Mild coronary calcifications (n = 42)	Moderate coronary calcifications (n = 26)	Heavy coronary calcifications (n = 37)	P value
Time from symptom onset to admission days, median [IQR]	7.0 (5.0; 9.0)	7.0 (5.0; 9.0)	7.0 (5.0–10.0)	6.5 (3.8; 9.3)	7.0 (4.0; 9.5)	0.492
Admission in ICU	53 (31.4%)	21 (32.8%)	17 (40.5%)	8 (30.8%)	7 (18.9%)	0.226
Treatment
Non-invasive ventilation	6 (3.6%)	1 (1.6%)	2 (4.8%)	2 (7.7%)	1 (2.7%)	0.539
Invasive mechanical ventilation	36 (21.3%)	17 (26.6%)	8 (19.0%)	4 (15.4%)	7 (18.9%)	0.604
Prone position	21 (12.4%)	10 (15.6%)	5 (11.9%)	2 (7.7%)	4 (10.8%)	0.735
Continuous renal replacement therapy	15 (8.9%)	6 (9.4%)	4 (9.5%)	3 (11.5%)	2 (5.4%)	0.829
Circulatory support	2 (1.2%)	2 (3.1%)	0 (0.0%)	0 (0.0%)	0 (0.0%)	0.269
Preventive ACT	108 (64.3%)	41 (65.1%)	28 (66.7%)	17 (65.4%)	22 (59.5%)	0.916
Curative ACT	54 (32%)	17 (26.6%)	13 (31.0%)	9 (34.6%)	15 (40.5%)	0.529
Antiviral treatment	21 (12.4%)	11 (17.2%)	3 (7.1%)	2 (7.7%)	5 (13.5%)	0.375
Clinical outcomes
Acute heart failure	10 (6.0%)	0 (0.0%)	4 (9.5%)	1 (3.8%)	5 (13.5%)	0.007
Arrhythmia	12 (7.1%)	4 (6.3%)	4 (9.5%)	1 (3.8%)	3 (8.1%)	0.810
Discharged	125 (74.0%)	57 (89.0%)	31 (73.8%)	17 (65.4%)	20 (54.1%)	0.001
Death at 30-days	41 (24.3%)	6 (9.4%)	10 (23.8%)	9 (34.6%)	16 (43.2%)	0.001
Death at 6-months	45 (26.6%)	7 (10.9%)	11 (26.2%)	10 (38.5%)	17 (45.9%)	0.001

Quantitative variables are expressed as medians with interquartile ranges in parentheses. Qualitative variables are expressed as raw numbers with percentages in parentheses;.

ACT Anticoagulant therapy; ICU, intensive care unit; IQR, interquartile range.

Bold indicates significant P value.